US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06384352 Phase 1
Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Ad...
Condition
Advanced Solid Tumors
Enrollment
500 pts
Location
United States, Australia, Canada
Sponsor
MediLink Therapeutics (Suzhou)
View Trial →
NCT07033026 Phase 2
Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study ...
Condition
Colorectal Cancer
Enrollment
136 pts
Location
United States, Georgia, South Korea
Sponsor
NGM Biopharmaceuticals, Inc
View Trial →
NCT04763343 Phase 3
Recruiting
Ketamine Treatment of Youth Suicide Attempters
Condition
Suicide, Attempted
Enrollment
60 pts
Location
United States
Sponsor
Tatiana Falcone, MD
View Trial →
NCT06930625 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acr...
Condition
Acromegaly
Enrollment
119 pts
Location
United States, Austria, Belgium
Sponsor
Debiopharm International SA
View Trial →
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
View Trial →
NCT07577843 Phase 3
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn...
Condition
Crohn Disease
Enrollment
460 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06681233 N/A
Recruiting
Feasibility Study of CBCT for IGRT in Cancer Patients
Condition
Head and Neck Cancers
Enrollment
50 pts
Location
United States
Sponsor
Varian, a Siemens Healthineers
View Trial →
NCT04181138 N/A
Recruiting
Primary Sclerosing Cholangitis in Children
Condition
Primary Sclerosing Cholangitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
View Trial →
NCT06476808 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses o...
Condition
High-grade Serous Ovarian Carcinoma (HGSOC)
Enrollment
240 pts
Location
United States, Canada, France
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07173985 N/A
Recruiting
Strategies for Optimizing a Mailed FIT Program in Appalachia
Condition
Colonic Neoplasms
Enrollment
550 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT06296186 N/A
Recruiting
Massed Prolonged Exposure for PTSD in Substance Use Treatment
Condition
Stress Disorders, Post-Traumatic
Enrollment
200 pts
Location
United States
Sponsor
Veterans Medical Research Foun
View Trial →
NCT05685303 N/A
Recruiting
Alleviant ALLAY-HF Study
Condition
Heart Failure
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Alleviant Medical, Inc.
View Trial →
NCT07695454 N/A
Recruiting
Imaging in Semaglutide Study
Condition
Type 2 Diabetes
Enrollment
10 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06974786 Phase 2
Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurabl...
Condition
Multiple Myeloma, Newly Diagnosed
Enrollment
100 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT07205718 Phase 1, Phase 2
Recruiting
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
273 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT07532603 Phase 2, Phase 3
Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Condition
Lichen Planopilaris
Enrollment
342 pts
Location
United States, Australia, Canada
Sponsor
Priovant Therapeutics, Inc.
View Trial →
NCT05734066 Phase 1, Phase 2
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants Wit...
Condition
Refractory Ewing Sarcoma
Enrollment
60 pts
Location
United States, Canada
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT07062588 Phase 2
Recruiting
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 Ge...
Condition
Osteogenesis Imperfecta (OI)
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Angitia Incorporated Limited
View Trial →
NCT05922657 N/A
Recruiting
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Condition
Heavy Menstrual Bleeding
Enrollment
300 pts
Location
United States
Sponsor
Channel Medsystems
View Trial →
NCT07439094 Phase 1, Phase 2
Recruiting
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lu...
Condition
Advanced Solid Tumors
Enrollment
140 pts
Location
United States
Sponsor
Chong Kun Dang Pharmaceutical
View Trial →
NCT05916339 Phase 4
Recruiting
AWARE: Management of ADHD in Autism Spectrum Disorder
Condition
ADHD
Enrollment
500 pts
Location
United States, Canada
Sponsor
Daniel Coury
View Trial →
NCT05437575 Phase 3
Recruiting
Prehospital Analgesia INtervention Trial (PAIN)
Condition
Traumatic Injury
Enrollment
994 pts
Location
United States
Sponsor
Jason Sperry
View Trial →
NCT05907629 N/A
Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vasc...
Condition
Stroke
Enrollment
300 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT04221542 Phase 1
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate C...
Condition
Prostate Cancer
Enrollment
505 pts
Location
United States, Australia, China
Sponsor
Amgen
View Trial →
NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) ...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
450 pts
Location
United States, Canada, Hungary
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 12 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology